Thomas Illmer

Researcher Next ID · RN-019404

Researcher · Medicine

Cologne, Estonia

Not currently recruitingFunding unknown

Research interests

Medicine

Acute Myeloid Leukemia Research

Chronic Lymphocytic Leukemia Research

Chronic Myeloid Leukemia Treatments

Lymphoma Diagnosis and Treatment

Hematopoietic Stem Cell Transplantation

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2213093
Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1903455
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1313984
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
Bone Marrow Transplantation · 2008 · https://doi.org/10.1038/bmt.2008.316
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Blood · 2006 · https://doi.org/10.1182/blood-2005-08-3167
P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate
Leukemia · 2004 · https://doi.org/10.1038/sj.leu.2403257
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
Blood · 2002 · https://doi.org/10.1182/blood.v99.12.4326

No projects listed.